ORIGINAL RESEARCH article
Front. Immunol.
Sec. Immunological Tolerance and Regulation
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1599480
This article is part of the Research TopicA New Era in the Treatment of Food AllergyView all 3 articles
Gut Commensal Bacteria-derived polysaccharide sub-micron particles induce antigen-specific, tolerogenic responses
Provisionally accepted
- 1University of California, Davis, Davis, California, United States
- 2University of Florida, Gainesville, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Roughly 10.8% (>26 million) Americans suffer from food allergies (FA) which, in severe cases, can be life threatening. Oral immunotherapy (OIT) offers a promising allergen-specific approach in the management of FA. However, due to risk of anaphylactic shock, there are significant concerns regarding its safety and must be carried out in the hospital under careful supervision by clinicians. These concerns may be addressed through delivery of the allergen in engineered nanoparticulate packages which may additionally improve therapeutic efficacy. Polysaccharide A (PSA), a commensal-derived molecule produced by the gut-symbiont Bacteroides fragilis, has shown tremendous potency in ameliorating inflammatory diseases in various mouse models by eliciting tolerogenic T cell activity. The tolerogenic capacity in combination with its polymeric structure makes PSA an intriguing biomaterial for the formulation of tolerogenic sub-micron particles. We hypothesized that encapsulation of protein antigen within PSA sub-micron particles (SMPs) would provide a particle platform capable of inducing robust specific tolerogenic responses for safer treatment of FA. In this body of work, we demonstrate the successful fabrication of tolerance-inducing sub-micron particles using the commensal-derived molecule, PSA. We reveal that PSA sub-micron particles can be easily loaded with ovalbumin (OVA), a surrogate for protein allergens, resist degradation in gastric fluid, and induce OVA-specific tolerogenic responses. Taken altogether, our findings give credence that PSA SMPs are ideally suited for OIT applications. Moreover, this study demonstrates that PSA SMPs have the potential to serve as a "plug and play" system capable of inducing specific tolerance to any encapsulated antigen.
Keywords: Polysaccharide a, Sub-micron particles, immunomodulatory, Dendritic Cells, T cells, Regulatory
Received: 04 Apr 2025; Accepted: 01 Sep 2025.
Copyright: © 2025 Harriman, Tu, Radoc, Kakwere and Lewis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jamal S Lewis, University of Florida, Gainesville, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.